Oral administration of 2-docosahexaenoyl lysophosphatidylcholine displayed anti-inflammatory effects on zymosan A-induced peritonitis

Inflammation

Volumn 34, Issue 3, 2011, Pages 147-160

  Hung, Nguyen Dang ^a   Kim, Mee Ree ^a   Sok, Dai Eun ^a  

^a Chungnam National University   (South Korea)

Author keywords

2 docosahexaenoyl lysoPC; anti inflammatory; nitric oxide LTC 4; PGE2; RAW 264.7 cell; zymosan A

Indexed keywords

2 (17 HYDROPEROXYDOCOSAHEXANEOYL)LYSOPHOSPHATIDYLCHOLINE; 2 DOCOSAHEXAENOYL LYSOPHOSPHATIDYLCHOLINE; ARACHIDONATE 15 LIPOXYGENASE; DOCOSAHEXAENOIC ACID; INTERLEUKIN 6; LEUKOTRIENE C4; LYSOPHOSPHATIDYLCHOLINE; NITRIC OXIDE; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ZYMOSAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; OXYGENATION; PERITONITIS;

ADMINISTRATION, ORAL; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARACHIDONATE 15-LIPOXYGENASE; CELL LINE; CELL SURVIVAL; DINOPROSTONE; DOCOSAHEXAENOIC ACIDS; HUMANS; KINETICS; LEUKOTRIENE C4; LYSOPHOSPHATIDYLCHOLINES; MALE; MICE; MICE, INBRED ICR; NITRIC OXIDE; OXIDATION-REDUCTION; PERITONITIS; SUBSTRATE SPECIFICITY; ZYMOSAN;

GLYCINE MAX; MUS;

EID: 79956121265     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-010-9218-z     Document Type: Article

References (55)

1. Serhan, C.N., and J. Savill. 2005. Resolution of inflammation: The beginning programs the end. Nature Immunology 6: 1191-1197. (Pubitemid 43045627)
2. Levy, B.D., C.B. Clish, B. Schmidt, K. Gronert, and C.N. Serhan. 2001. Lipid mediator class switching during acute inflammation: Signals in resolution. Nature Immunology 2(7): 612-619. (Pubitemid 32677628)
3. Serhan, C.N. 2005. Novel eicosanoid and docosanoid mediators: Resolvins, docosatrienes, and neuroprotectins. Current Opinion in Clinical Nutrition and Metabolic Care 8: 115-121. (Pubitemid 40289470)
4. Daleau, P. 1999. Lysophosphatidylcholine, a metabolite which accumulates early in myocardium during ischemia, reduces gap junctional coupling in cardiac cells. Journal of Molecular and Cellular Cardiology 31: 1391-1401. (Pubitemid 29335669)
5. Fuchs, B., J. Schiller, U. Wagner, H. Häntzschel, and K. Arnold. 2005. The phosphatidylcholine /lysophosphatidylcholine ratio in human plasma is an indicator of the severity of rheumatoid arthritis: Investigations by 31P NMR and MALDI-TOF MS. Clinical Biochemistry 38: 925-933. (Pubitemid 41316652)
6. Muralikrishna Adibhatla, R., and J.F. Hatcher. 2006. Phospholipase A2, reactive oxygen species, and lipid peroxidation in cerebral ischemia. Free Radical Biology & Medicine 40: 376-387. (Pubitemid 43139673)
7. 2 in leukocyte activation and inflammatory responses. Atherosclerosis 191: 54-62.
8. Fuentes, L., M. Hernández, F.J. Fernández-Avilés, M.S. Crespo, and M.L. Nieto. 2002. Cooperation between secretory phospholipase A2 and TNF-receptor superfamily signaling: implications for the inflammatory response in atherogenesis. Circulation Research 91: 681-688. (Pubitemid 35204950)
9. Colles, S.M., and G.M. Chisolm. 2000. Lysophosphatidylcholineinduced cellular injury in cultured fibroblasts involves oxidative events. Journal of Lipid Research 41: 1188-1198. (Pubitemid 30666883)
10. Matsubara,M., and K. Hasegawa. 2005. Benidipine, a dihydropyridinecalcium channel blocker, prevents lysophosphatidylcholine-induced injury and reactive oxygen species production in human aortic endothelial cells. Atherosclerosis 178: 57-66. (Pubitemid 39600816)
11. Takeshita, S., N. Inoue, D. Gao, Y. Rikitake, S. Kawashima, R. Tawa, H. Sakurai, and M. Yokoyama. 2000. Lysophosphatidylcholine enhances superoxide anions production via endothelial NADH/NADPH oxidase. Journal of Atherosclerosis and Thrombosis 7: 238-246.
12. Silliman, C.C., D.J. Elzi, D.R. Ambruso, R.J. Musters, C. Hamiel, R.J. Harbeck, A.J. Paterson, A.J. Bjornsen, T.H. Wyman, M. Kelher, K.M. England, N. McLaughlin-Malaxecheberria, C.C. Barnett, J. Aiboshi, and A. Bannerjee. 2003. Lysophosphatidylcholines prime the NADPH oxidase and stimulate multiple neutrophil functions through changes in cytosolic calcium. Journal of Leukocyte Biology 73: 511-524. (Pubitemid 38040097)
13. Park, C.H., M.R. Kim, J.M. Han, T.S. Jeong, and D.E. Sok. 2009. Lysophosphatidylcholine exhibits a selective cytotoxicity, accompanied by ROS formation, in RAW 264.7 macrophages. Lipids 44: 425-435.
14. Huang, L.S., M.R. Kim, and D.E. Sok. 2008. Regulation of lipoxygenase activity by polyunsaturated lysophosphatidylcholines or their oxygenation derivatives. Journal of Agricultural and Food Chemistry 56: 7808-7814.
15. Funk, C.D. 2001. Prostaglandins and leukotrienes: Advances in eicosanoid biology. Science 294: 1871-1875. (Pubitemid 33101574)
16. Hung, N.D., M.R. Kim, and D.E. Sok. 2009. Anti-inflammatory action of arachidonoyl lysophosphatidylcholine or 15-hydroperoxy derivative in zymosan A-induced peritonitis. Prostaglandins & Other Lipid Mediators 90(3-4): 105-111.
17. Huang, L.S., N.D. Hung, M.R. Kim, and D.E. Sok. 2010. Lysophosphatidylcholine containing docosahexaenoic acid at the sn-1 position is anti-inflammatory. Lipids 45(3): 225-236.
18. Subbaiah, P.V., M. Liu, and F. Paltauf. 1994. Role of sn-2 acyl group of phosphatidylcholine in determining the positional specificity of lecithin-cholesterol acyltransferase. Biochemistry 33 (45): 13259-13266. (Pubitemid 24373240)
19. Subbaiah, P.V., and M. Liu. 1996. Comparative studies on substrate specificity of lecithin-cholesterol acyltransferase towards the molecular species of phospholipids in plasma of 14 vertebrates. Journal of Lipid Research 37: 113-122. (Pubitemid 26052624)
20. Gauster, M., G. Rechberger, A. Sovic, G. Horl, E. Steyrer, W. Sattler, and S. Frank. 2005. Endothelial lipase releases saturated and unsaturated fatty acids of high density lipoprotein phosphatidylcholine. Journal of Lipid Research 46: 1517-1525. (Pubitemid 43109817)
21. Chen, S., and P.V. Subbaiah. 2007. Phospholipid and fatty acid specificity of endothelial lipase: Potential role of the enzyme in the delivery of docosahexaenoic acid (DHA) to tissues. Biochimica et Biophysica Acta 1771(10): 1319-1328. (Pubitemid 47499233)
22. Cedars, A., C.M. Jenkins, D.J. Mancuso, and R.W. Gross. 2009. Calcium-independent phospholipases in the heart: Mediators of cellular signaling, bioenergetics, and ischemia-induced electrophysiologic dysfunction. Journal of Cardiovascular Pharmacology 53(4): 277-289.
23. Satouchi, K., M. Sakaguchi, M. Shirakawa, K. Hirano, and T. Tanaka. 1994. Lysophosphatidylcholine from white muscle of bonito Euthynnus pelamis (Linnaeus): Involvement of phospholipase A1 activity for its production. Biochimica et Biophysica Acta 1214(3): 303-308. (Pubitemid 24312456)
24. Huang, L.S., M.R. Kim, and D.E. Sok. 2006. Linoleoyl lysophosphatidylcholine is an efficient substrate for soybean lipoxygenase-1. Archives of Biochemistry and Biophysics 455: 119-126. (Pubitemid 44708847)
25. Huang, L.S., M.R. Kim, and D.E. Sok. 2007. Oxygenation of 1-docosahexaenoyl lysophosphatidylcholine by lipoxygenases; conjugated hydroperoxydiene and dihydroxytriene derivatives. Lipids 42: 981-990. (Pubitemid 350127312)
26. Huang, L.S., M.R. Kim, and D.E. Sok. 2008. Oxygenation of arachidonoyl lysophospholipids by lipoxygenases from soybean, porcine leukocyte, or rabbit reticulocyte. Journal of Agricultural and Food Chemistry 56: 1224-1232.
27. Tokumura, A., J. Sinomiya, S. Kishimoto, T. Tanaka, K. Kogure, T. Sugiura, K. Satouchi, K. Waku, and K. Fukuzawa. 2002. Human platelets respond differentially to lysophosphatidic acids having a highly unsaturated fatty acyl group and alkyl ether-linked lysophosphatidic acids. The Biochemical Journal 365(3): 617-628. (Pubitemid 34864443)
28. Bligh, E.G., and W.J. Dyer. 1959. A rapid method of total lipid extraction and purification. Canadian Journal of Biochemistry and Physiology 37: 911-917.
29. Polette, A., C. Deshayes, B. Chantegrel, M. Croset, J.M. Armstrong, and M. Lagarde. 1999. Synthesis of acetyl, docosahexaenoyl-glycerophosphocholine and its characterization using nuclear magnetic resonance. Lipids 34(12): 1333-1337. (Pubitemid 30044273)
30. Cho, Y.S., H.S. Kim, C.H. Kim, and H.G. Cheon. 2006. Application of the ferrous oxidation-xylenol orange assay for the screening of 5-lipoxygenase inhibitors. Analytical Biochemistry 351: 62-68.
31. Saw, C.L., Y. Huang, and A.N. Kong. 2010. Synergistic antiinflammatory effects of low doses of curcumin in combination with polyunsaturated fatty acids: Docosahexaenoic acid or eicosapentaenoic acid. Biochemical Pharmacology 79(3): 421-430.
32. Aldridge, C., A. Razzak, T.A. Babcock, W.S. Helton, and N.J. Espat. 2008. Lipopolysaccharide-stimulated RAW 264.7 macrophage inducible nitric oxide synthase and nitric oxide production is decreased by an omega-3 fatty acid lipid emulsion. The Journal of Surgical Research 149(2): 296-302.
33. Kobori, M., H. Nakayama, K. Fukushima, M. Ohnishi-Kameyama, H. Ono, T. Fukushima, Y. Akimoto, S. Masumoto, C. Yukizaki, Y. Hoshi, T. Deguchi, and M. Yoshida. 2008. Bitter gourd suppresses lipopolysaccharide-induced inflammatory responses. Journal of Agricultural and Food Chemistry 56(11): 4004-4011. (Pubitemid 351967939)
34. Moon, Y., and J.J. Pestka. 2003. Deoxynivalenol-induced mitogen-activated protein kinase phosphorylation and IL-6 expression in mice suppressed by fish oil. The Journal of Nutritional Biochemistry 14(12): 717-726. (Pubitemid 38019050)
35. Doherty, N.S., P. Poubelle, P. Borgeat, T.H. Beaver, G.L. Westrich, and N.L. Schrader. 1985. Intraperitoneal injection of zymosan in mice induces pain, inflammation and the synthesis of peptidoleukotrienes and prostaglandin E2. Prostaglandins 30: 769-789. (Pubitemid 16199279)
36. Rao, T.S., J.L. Currie, A.F. Shaffer, and P.C. Isakson. 1994. In vivo characterization of zymosan-induced mouse peritoneal inflammation. The Journal of Pharmacology and Experimental Therapeutics 269: 917.
37. Byrum, R.S., J.L. Goulet, J.N. Snouwaert, R.J. Griffiths, and B.H. Koller. 1999. Determination of the contribution of cysteinyl leukotrienes and leukotriene B4 in acute inflammatory responses using 5-lipoxygenase-and leukotriene A4 hydrolase-deficient mice. Journal of Immunology 163: 6810-6819.
38. Forrest, M.J., P.J. Jose, and T.J. Williams. 1986. Kinetics of the generation and action of chemical mediators in zymosan-induced inflammation of the rabbit peritoneal cavity. British Journal of Pharmacology 89: 719-730. (Pubitemid 17200578)
39. Kolaczkowska, E., M. Barteczko, B. Plytycz, and B. Arnold. 2008. Role of lymphocytes in the course of murine zymosan-induced peritonitis. Inflammation Research 57(6): 272-278.
40. Arita, M., F. Bianchini, J. Aliberti, A. Sher, N. Chiang, S. Hong, R. Yang, N.A. Petasis, and C.N. Serhan. 2005. Stereochemical assignment, anti-inflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1. The Journal of Experimental Medicine 201: 713-722. (Pubitemid 40395117)
41. Sun, Y.P., S.F. Oh, J. Uddin, R. Yang, K. Gotlinger, E. Campbell, Colgan, N.A. Petasis, and C.N. Serhan. 2007. Resolvin D1 and its aspirin-triggered 17R epimer. Stereochemical assignments, antiinflammatory properties, and enzymatic inactivation. The Journal of Biological Chemistry 282(13): 9323-9334. (Pubitemid 47104612)
42. Bannenberg, G., R.L. Moussignac, K. Gronert, P.R. Devchand, B.A. Schmidt, W.J. Guilford, J.G. Bauman, B. Subramanyam, H.D. Perez, J.F. Parkinson, and C.N. Serhan. 2004. Lipoxins and novel 15-epilipoxin analogs display potent anti-inflammatory actions after oral administration. British Journal of Pharmacology 143: 43-52.
43. Rao, N.L., P.J. Dunford, X. Xue, X. Jiang, K.A. Lundeen, F. Coles, J.P. Riley, K.N. Williams, C.A. Grice, J.P. Edwards, L. Karlsson, and A.M. Fourie. 2007. Anti-inflammatory activity of a potent, selective leukotriene A4 hydrolase inhibitor in comparison with the 5-lipoxygenase inhibitor zileuton. The Journal of Pharmacology and Experimental Therapeutics 321(3): 1154-1160. (Pubitemid 46762702)
44. 2 plays a key role in zymosan-induced mouse pleurisy. The Journal of Pharmacology and Experimental Therapeutics 325(2): 601-609.
45. Thiès, F., M.C. Delachambre, M. Bentejac, M. Lagarde, and T. Lecerf. 1992. Unsaturated fatty acids esterified in 2-acyl-1- lysophosphatidylcholine bound to albumin are more efficiently taken up by the young rat brain than the unesterified form. Journal of Neurochemistry 59(3): 1110-1116.
46. Bernoud, N., L. Fenart, P. Molière, M.P. Dehouck, M. Lagarde, R. Cecchelli, and J. Lecerf. 1999. Preferential transfer of 2-docosahexaenoyl-1- lysophosphatidylcholine through an in vitro bloodbrain barrier over unesterified docosahexaenoic acid. Journal of Neurochemistry 72(1): 338-3345.
47. Hong, S., K. Gronert, P.R. Devchand, R.L. Moussignac, and C.N. Serhan. 2003. Novel docosatrienes and 17 S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. Autacoids in anti-inflammation. Journal of Biological Chemistry 278(17): 14677-14687. (Pubitemid 36799790)
48. Guzik, T.J., R. Korbut, and T. Adamek-Guzik. 2003. Nitric oxide and superoxide in inflammation and immune regulation. Journal of Physiology and Pharmacology 54(4): 469-487. (Pubitemid 38029745)
49. Bloodsworth, A., V.B. O'Donnell, and B.A. Freeman. 2000. Nitric oxide regulation of free radical-and enzyme-mediated lipid and lipoprotein oxidation. Arteriosclerosis, Thrombosis, and Vascular Biology 20(7): 1707-1715. (Pubitemid 30470584)
50. Triggiani, M., A.N. Fonteh, and F.H. Chilton. 1992. Factors that influence the proportions of platelet-activating factor and 1-acyl-2- acetyl-sn-glycero-3-phosphocholine synthesized by the mast cell. The Biochemical Journal 286(2): 497-503.
51. Kolaczkowska, E., B. Arnold, and G. Opdenakker. 2008. Gelatinase B/MMP-9 as an inflammatory marker enzyme in mouse zymosan peritonitis": comparison of phase-specific production by mast cells, macrophages, and neutrophils. Immunobiology 213: 109-124.
52. Kolaczkowska, E., S. Shahzidi, R. Seljelid, N. Van Rooijen, and B. Plytycz. 2002. Early vascular permeability in murine experimental peritonitis is comediated by residential macrophages and mast cells: Crucial involvement of macrophage-derived cysteinyl-leukotrienes. Inflammation 26: 61-71. (Pubitemid 34274484)
53. Bazan, N.G. 2008. Neurotrophins induce neuroprotective signaling in the retinal pigment epithelial cell by activating the synthesis of the anti-inflammatory and anti-apoptotic neuroprotectin D1. Advances in Experimental Medicine and Biology 613: 39-44.
54. Serhan, C.N., R. Yang, K. Martinod, K. Kasuga, P.S. Pillai, T.F. Porter, S.F. Oh, and M. Spite. 2009. Maresins: Novel macrophage mediators with potent antiinflammatory and proresolving actions. The Journal of Experimental Medicine 206: 15-23.
55. Spite, M., L.V. Norling, L. Summers, R. Yang, D. Cooper, N.A. Petasis, R.J. Flower, M. Perretti, and C.N. Serhan. 2009. Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis. Nature 461(7268): 1287-1291.